TCR Reading Tools
How to cite item
Promise of vandetanib, a FDA-approved RET kinase inhibitor, for the treatment of
RET
fusion-positive lung adenocarcinoma
Citation Format
ABNT
APA
BibTeX
CBE
EndNote - EndNote format (Macintosh & Windows)
MLA
ProCite - RIS format (Macintosh & Windows)
RefWorks
Reference Manager - RIS format (Windows only)
Turabian
@article{{TCR}{8825}, author = {Kohno, T.}, title = {Promise of vandetanib, a FDA-approved RET kinase inhibitor, for the treatment of <em>RET</em> fusion-positive lung adenocarcinoma}, journal = {Translational Cancer Research}, volume = {5}, number = {Suppl 2}, year = {2016}, url = {https://tcr.amegroups.org/article/view/8825} }